In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of ORIC Pharmaceuticals Inc (NASDAQ: ORIC) closed at $12.78 in the last session, down -3.91% from day before closing price of $13.3. In other words, the price has decreased by -$3.91 from its previous closing price. On the day, 1.12 million shares were traded. ORIC stock price reached its highest trading level at $13.35 during the session, while it also had its lowest trading level at $12.62.
Ratios:
We take a closer look at ORIC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 16.13 and its Current Ratio is at 16.13. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On July 08, 2025, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $15.
On October 31, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $20.Wells Fargo initiated its Overweight rating on October 31, 2024, with a $20 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 06 ’25 when Piscitelli Dominic sold 11,000 shares for $14.52 per share. The transaction valued at 159,719 led to the insider holds 48,317 shares of the business.
Chacko Jacob sold 37,461 shares of ORIC for $461,520 on Oct 06 ’25. The PRESIDENT AND CEO now owns 531,419 shares after completing the transaction at $12.32 per share. On Oct 06 ’25, another insider, Dominic Piscitelli, who serves as the Officer of the company, bought 50,000 shares for $14.50 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORIC now has a Market Capitalization of 1241231744 and an Enterprise Value of 966803776.
Stock Price History:
The Beta on a monthly basis for ORIC is 1.62, which has changed by 0.4013158 over the last 52 weeks, in comparison to a change of 0.13837254 over the same period for the S&P500. Over the past 52 weeks, ORIC has reached a high of $14.93, while it has fallen to a 52-week low of $3.90. The 50-Day Moving Average of the stock is 15.17%, while the 200-Day Moving Average is calculated to be 42.44%.
Shares Statistics:
According to the various share statistics, ORIC traded on average about 1.29M shares per day over the past 3-months and 1860950 shares per day over the past 10 days. A total of 86.19M shares are outstanding, with a floating share count of 56.09M. Insiders hold about 42.25% of the company’s shares, while institutions hold 63.04% stake in the company. Shares short for ORIC as of 1759190400 were 11242529 with a Short Ratio of 8.68, compared to 1756425600 on 8174386. Therefore, it implies a Short% of Shares Outstanding of 11242529 and a Short% of Float of 11.72.
Earnings Estimates
The stock of ORIC Pharmaceuticals Inc (ORIC) is currently being evaluated by 11.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.38, with high estimates of -$0.29 and low estimates of -$0.49.
Analysts are recommending an EPS of between -$1.29 and -$2.53 for the fiscal current year, implying an average EPS of -$1.71. EPS for the following year is -$1.71, with 11.0 analysts recommending between -$1.03 and -$2.84.
